Protective Immunity in Mice Immunized With P. vivax MSP1(19)-Based Formulations and Challenged With P. berghei Expressing PvMSP1(19)

The lack of continuous in vitro cultures has been an obstacle delaying pre-clinical testing of Plasmodium vivax vaccine formulations based on known antigens. In this study, we generated a model to test available formulations based on the P. vivax MSP1(19) antigen. The Plasmodium berghei strains ANKA...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobrescu, Irina, de Camargo, Tarsila Mendes, Gimenez, Alba Marina, Murillo, Oscar, Amorim, Kelly Nazaré da Silva, Marinho, Claudio Romero Farias, Soares, Irene Silva, Boscardin, Silvia Beatriz, Bargieri, Daniel Youssef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045055/
https://www.ncbi.nlm.nih.gov/pubmed/32153555
http://dx.doi.org/10.3389/fimmu.2020.00028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045055/
https://www.ncbi.nlm.nih.gov/pubmed/32153555
http://dx.doi.org/10.3389/fimmu.2020.00028

Ejemplares similares